1. The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale Am Heart J, 2009. 158(3): p. 327-334 e4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio n&list_uids=19699853 2. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR) Akhter, N., et al. Am Heart J, 2009. 157(1): p. 141-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio n&list_uids=19081410 3. Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative Amsterdam, E.A., et al. Am Heart J, 2009. 158(5): p. 748-754 e1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio n&list_uids=19853692 4. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities Ang, D.S., et al. Am Heart J, 2009. 158(1): p. 133-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio n&list_uids=19540403 5. Blood pressure paradox in patients with non-ST-segment elevation acute coronary syndromes: results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) quality improvement initiative Bangalore, S., et al. Am Heart J, 2009. 157(3): p. 525-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio n&list_uids=19249424 6. Evidence-based medication use among Chinese patients with acute coronary
Transcript
1. The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale
Am Heart J, 2009. 158(3): p. 327-334 e4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19699853 2. Gender differences among patients with acute coronary syndromes undergoing
percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR)
Akhter, N., et al. Am Heart J, 2009. 157(1): p. 141-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19081410 3. Comparative trends in guidelines adherence among patients with
non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiative
Amsterdam, E.A., et al. Am Heart J, 2009. 158(5): p. 748-754 e1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19853692 4. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute
coronary syndrome independent of echocardiographic abnormalities Ang, D.S., et al. Am Heart J, 2009. 158(1): p. 133-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19540403 5. Blood pressure paradox in patients with non-ST-segment elevation acute
coronary syndromes: results from 139,194 patients in the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the American College of Cardiology/American Heart Association Guidelines (CRUSADE) quality improvement initiative
Bangalore, S., et al. Am Heart J, 2009. 157(3): p. 525-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19249424 6. Evidence-based medication use among Chinese patients with acute coronary
syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study
Bi, Y., et al. Am Heart J, 2009. 157(3): p. 509-516 e1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19249422 7. The paradoxical use of cardiac catheterization in patients with non-ST-elevation
acute coronary syndromes: lessons from the Can Rapid Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the ACC /AHA Guidelines (CRUSADE) Quality Improvement Initiative
Cohen, M.G., et al. Am Heart J, 2009. 158(2): p. 263-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
and reduced mortality in patients with acute coronary syndrome using guideline-based critical care pathways
Corbelli, J.C., et al. Am Heart J, 2009. 157(1): p. 61-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19081398 9. Adding intravenous unfractionated heparin to standard enoxaparin causes
excessive anticoagulation not detected by activated clotting time: results of the STACK-on to ENOXaparin (STACKENOX) study
Drouet, L., C. Bal dit Sollier, and J. Martin Am Heart J, 2009. 158(2): p. 177-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19619692 10. Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for
in-hospital mortality in patients with acute coronary syndrome in Canada Elbarouni, B., et al. Am Heart J, 2009. 158(3): p. 392-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19699862 11. The expanded Global Registry of Acute Coronary Events: baseline
characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes
Goodman, S.G., et al. Am Heart J, 2009. 158(2): p. 193-201 e1-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19619694 12. Cilostazol in addition to aspirin and clopidogrel improves long-term outcomes
after percutaneous coronary intervention in patients with acute coronary syndromes: a randomized, controlled study
Han, Y., et al. Am Heart J, 2009. 157(4): p. 733-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19332203 13. Use of beta-blockers and effects on heart rate and blood pressure post-acute
coronary syndromes: are we on target? Herman, M., et al. Am Heart J, 2009. 158(3): p. 378-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19699860 14. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist,
with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial
James, S., et al. Am Heart J, 2009. 157(4): p. 599-605. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19332184 15. Fondaparinux compared to enoxaparin in patients with acute coronary
syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk
Joyner, C.D., et al. Am Heart J, 2009. 157(3): p. 502-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19249421 16. Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute
Coronary Events
Pieper, K.S., et al. Am Heart J, 2009. 157(6): p. 1097-105. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19464422 17. Effect of prasugrel versus clopidogrel on outcomes among patients with acute
coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudy
Pride, Y.B., et al. Am Heart J, 2009. 158(3): p. e21-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19699846 18. Temporal trends and patterns of early clopidogrel use across the spectrum of
acute coronary syndromes Rao, R.V., et al. Am Heart J, 2009. 157(4): p. 642-50 e1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19332190 19. Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes:
short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial
Sculpher, M.J., et al. Am Heart J, 2009. 157(5): p. 845-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19376310 20. Impact of female gender and transradial coronary stenting with maximal
antiplatelet therapy on bleeding and ischemic outcomes Tizon-Marcos, H., et al. Am Heart J, 2009. 157(4): p. 740-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19332204 21. Incidence, distribution, and prognostic impact of occluded culprit arteries among
patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography
Wang, T.Y., et al. Am Heart J, 2009. 157(4): p. 716-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19332201 22. Detection of myocardial injury in patients with unstable angina using a novel
nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial
Wilson, S.R., et al. Am Heart J, 2009. 158(3): p. 386-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19699861 23. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in
patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial
Yong, G., et al. Am Heart J, 2009. 157(1): p. 60 e1-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19081397 24. Rationale and design of China intensive lipid lowering with statins in acute
coronary syndrome: the CHILLAS study Zhao, S.P., et al. Am Heart J, 2009. 158(4): p. 509-512 e1. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19781407 25. Effect of cholesterol crystals on plaques and intima in arteries of patients with
acute coronary and cerebrovascular syndromes Abela, G.S., et al. Am J Cardiol, 2009. 103(7): p. 959-68. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19327423 26. Relation of patient age and mortality to reported contraindications to early
beta-blocker use for non-ST-elevation acute coronary syndrome Allen LaPointe, N.M., et al. Am J Cardiol, 2009. 104(10): p. 1324-9.
27. Safety of contrast in stress echocardiography in stable patients and in patients
with suspected acute coronary syndrome but negative 12-hour troponin Anantharam, B., et al. Am J Cardiol, 2009. 104(1): p. 14-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19576314 28. Influence of age on use of cardiac catheterization and associated outcomes in
patients with non-ST-elevation acute coronary syndromes Bagnall, A.J., et al. Am J Cardiol, 2009. 103(11): p. 1530-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19463511 29. Comparison of outcomes in patients > or =70 years versus <70 years after
transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome
Bagur, R., et al. Am J Cardiol, 2009. 104(5): p. 624-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19699334 30. Usefulness of age and gender in the early triage of patients with acute chest pain
having cardiac computed tomographic angiography Bamberg, F., et al. Am J Cardiol, 2009. 104(9): p. 1165-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19840556 31. Effect of blood hematocrit and erythrocyte deformability on adenosine
5'-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy
Cecchi, E., et al. Am J Cardiol, 2009. 104(6): p. 764-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19733708
32. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients
Cuisset, T., et al. Am J Cardiol, 2009. 104(8): p. 1078-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19801028 33. Patient characteristics associated with the choice of triple antithrombotic therapy
in acute coronary syndromes Depta, J.P., et al. Am J Cardiol, 2009. 104(9): p. 1171-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19840557 34. Impact of admission glucose level and presence of diabetes mellitus on mortality
in patients with non-ST-segment elevation acute coronary syndrome treated conservatively
Dziewierz, A., et al. Am J Cardiol, 2009. 103(7): p. 954-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19327422 35. Comparison of men and women with acute coronary syndrome in six Middle
Eastern countries El-Menyar, A., et al. Am J Cardiol, 2009. 104(8): p. 1018-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19801017 36. Usefulness of diabetes mellitus to predict long-term outcomes in patients with
unstable angina pectoris Farkouh, M.E., et al. Am J Cardiol, 2009. 104(4): p. 492-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19660600 37. Timing and duration of myocardial ischemia on Holter monitoring following
percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis)
Gibson, C.M., et al.
Am J Cardiol, 2009. 104(1): p. 36-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19576318 38. Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global
Registry of Acute Coronary Events [GRACE]) Goldberg, R.J., et al. Am J Cardiol, 2009. 103(5): p. 598-603. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19231319 39. Thrombocytopenia in patients with an acute coronary syndrome (from the Global
Registry of Acute Coronary Events [GRACE]) Gore, J.M., et al. Am J Cardiol, 2009. 103(2): p. 175-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19121432 40. Comparison of treatment and outcome of acute coronary syndrome in patients
with versus patients without diabetes mellitus Hasin, T., et al. Am J Cardiol, 2009. 103(6): p. 772-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19268730 41. Prognostic value of admission fasting glucose levels in patients with acute
coronary syndrome Kolman, L., et al. Am J Cardiol, 2009. 104(4): p. 470-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19660596 42. Impact of gender and antithrombin strategy on early and late clinical outcomes in
patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial) Lansky, A.J., et al. Am J Cardiol, 2009. 103(9): p. 1196-203. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19406258 43. Prognostic impact of types of atrial fibrillation in acute coronary syndromes
Lau, D.H., et al. Am J Cardiol, 2009. 104(10): p. 1317-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19892044 44. Usefulness of elevations in serum choline and free F2)-isoprostane to predict
30-day cardiovascular outcomes in patients with acute coronary syndrome LeLeiko, R.M., et al. Am J Cardiol, 2009. 104(5): p. 638-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19699337 45. Comparison of site-reported and core laboratory-reported creatine kinase-MB
values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY)
Linefsky, J.P., et al. Am J Cardiol, 2009. 104(10): p. 1330-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19892046 46. Severity of coronary arterial stenoses responsible for acute coronary syndromes Manoharan, G., et al. Am J Cardiol, 2009. 103(9): p. 1183-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19406256 47. Predictors of early discontinuation of evidence-based medicine after acute
coronary syndrome Melloni, C., et al. Am J Cardiol, 2009. 104(2): p. 175-81. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19576342 48. Anemia for risk assessment of patients with acute coronary syndromes Meneveau, N., et al. Am J Cardiol, 2009. 103(4): p. 442-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19195499 49. Effect of culprit-lesion remodeling versus plaque rupture on three-year outcome
in patients with acute coronary syndrome Okura, H., et al. Am J Cardiol, 2009. 103(6): p. 791-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19268733 50. Current use of beta blockers in patients with reactive airway disease who are
hospitalized with acute coronary syndromes Olenchock, B.A., et al. Am J Cardiol, 2009. 103(3): p. 295-300. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19166678 51. Comparison of the effects of ramipril versus telmisartan on high-sensitivity
C-reactive protein and endothelial progenitor cells after acute coronary syndrome Porto, I., et al. Am J Cardiol, 2009. 103(11): p. 1500-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19463506 52. Effectiveness of myocardial perfusion scintigraphy to predict coronary anatomy in
patients with non-ST elevation acute coronary syndrome Potter, B.J., et al. Am J Cardiol, 2009. 104(5): p. 644-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19699338 53. Acute effects of statin therapy on coronary atherosclerosis following an acute
coronary syndrome Rodes-Cabau, J., et al. Am J Cardiol, 2009. 104(6): p. 750-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19733706 54. Arterial access-site-related outcomes of patients undergoing invasive coronary
procedures for acute coronary syndromes (from the ComPaRison of Early Invasive and Conservative Treatment in Patients With Non-ST-ElevatiOn Acute Coronary Syndromes [PRESTO-ACS] Vascular Substudy)
Sciahbasi, A., et al. Am J Cardiol, 2009. 103(6): p. 796-800. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19268734 55. Relation of death within 90 days of non-ST-elevation acute coronary syndromes
to variability in electrocardiographic morphology Syed, Z., et al. Am J Cardiol, 2009. 103(3): p. 307-11. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19166680 56. Comparison of drug-eluting stents and bare-metal stents for the treatment of
unprotected left main coronary artery disease in acute coronary syndromes Tamburino, C., et al. Am J Cardiol, 2009. 103(2): p. 187-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19121434 57. Seasonal variation in lipids in patients following acute coronary syndrome on
fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study)
Tung, P., et al. Am J Cardiol, 2009. 103(8): p. 1056-60. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19361589 58. Relation of body mass index to mortality after development of heart failure due to
acute coronary syndrome Wu, A.H., et al. Am J Cardiol, 2009. 103(12): p. 1736-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19539085 59. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing
contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Xinwei, J., et al. Am J Cardiol, 2009. 104(4): p. 519-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19660605
60. Clinical significance of borderline elevated troponin I levels across different assays in patients with suspected acute coronary syndrome
Zahid, M., et al. Am J Cardiol, 2009. 104(2): p. 164-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19576340 61. Prognosis of patients suffering an acute coronary syndrome while already under
chronic clopidogrel therapy Bonello, L., et al. Catheter Cardiovasc Interv, 2009. 73(7): p. 866-70. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19198009 62. Effectiveness of the transradial approach to reduce bleedings in patients
undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes
De Carlo, M., et al. Catheter Cardiovasc Interv, 2009. 74(3): p. 408-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19360863 63. Is computed tomography coronary angiography the most accurate and effective
noninvasive imaging tool to evaluate patients with acute chest pain in the emergency department? CT coronary angiography is the most accurate and effective noninvasive imaging tool for evaluating patients presenting with chest pain to the emergency department: antagonist viewpoint
n&list_uids=19808601 64. Is computed tomography coronary angiography the most accurate and effective
noninvasive imaging tool to evaluate patients with acute chest pain in the emergency department?: CT coronary angiography is the most accurate and effective noninvasive imaging tool for evaluating patients presenting with chest pain to the emergency department
Hoffmann, U. and F. Bamberg Circ Cardiovasc Imaging, 2009. 2(3): p. 251-63; discussion 263. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19808600
65. Early stent thrombosis in patients with acute coronary syndromes treated with
drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial
Aoki, J., et al. Circulation, 2009. 119(5): p. 687-98. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19171852 66. Quality of care for acute coronary syndrome patients with known atherosclerotic
disease: results from the Get With the Guidelines Program Brilakis, E.S., et al. Circulation, 2009. 120(7): p. 560-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19652090 67. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes Jansson, A.M., et al. Circulation, 2009. 119(25): p. 3181-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19528340 68. Cardiovascular death and nonfatal myocardial infarction in acute coronary
syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up
Marcucci, R., et al. Circulation, 2009. 119(2): p. 237-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19118249 69. Evaluation of the glycometabolic effects of ranolazine in patients with and without
diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial Morrow, D.A., et al. Circulation, 2009. 119(15): p. 2032-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19349325 70. Effect of the novel thienopyridine prasugrel compared with clopidogrel on
spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the
classification system from the universal definition of myocardial infarction Morrow, D.A., et al. Circulation, 2009. 119(21): p. 2758-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19451347 71. Baseline risk of major bleeding in non-ST-segment-elevation myocardial
infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score
Subherwal, S., et al. Circulation, 2009. 119(14): p. 1873-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19332461 72. Incidence and prognostic significance of thrombocytopenia developed during
acute coronary syndrome in contemporary clinical practice Wang, T.Y., et al. Circulation, 2009. 119(18): p. 2454-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19398666 73. Impact of hospitalization for acute coronary events on subsequent mortality in
patients with chronic heart failure Abrahamsson, P., et al. Eur Heart J, 2009. 30(3): p. 338-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19001475 74. Improving clinical outcomes by reducing bleeding in patients with
non-ST-elevation acute coronary syndromes Budaj, A., et al. Eur Heart J, 2009. 30(6): p. 655-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=18713759 75. Diverging associations of an intended early invasive strategy compared with
actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias
Hirsch, A., et al. Eur Heart J, 2009. 30(6): p. 645-54.
76. Prognostic value of circulating chromogranin A levels in acute coronary
syndromes Jansson, A.M., et al. Eur Heart J, 2009. 30(1): p. 25-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19028779 77. Associations of major bleeding and myocardial infarction with the incidence and
timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial
Mehran, R., et al. Eur Heart J, 2009. 30(12): p. 1457-66. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19351691 78. Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel
in the TRITON-TIMI 38 trial Michelson, A.D., et al. Eur Heart J, 2009. 30(14): p. 1753-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19435740 79. Expression of stromal-cell-derived factor-1 on circulating platelets is increased in
patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells
Stellos, K., et al. Eur Heart J, 2009. 30(5): p. 584-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19109356 80. Lipid-rich plaque and myocardial perfusion after successful stenting in patients
with non-ST-segment elevation acute coronary syndrome: an optical coherence tomography study
Tanaka, A., et al. Eur Heart J, 2009. 30(11): p. 1348-55. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19383736
81. Temporal management patterns and outcomes of non-ST elevation acute
coronary syndromes in patients with kidney dysfunction Wong, J.A., et al. Eur Heart J, 2009. 30(5): p. 549-57. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19201761 82. Enhanced expression of haemoglobin scavenger receptor in accumulated
macrophages of culprit lesions in acute coronary syndromes Yunoki, K., et al. Eur Heart J, 2009. 30(15): p. 1844-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19556258 83. A comparison between B-type natriuretic peptide, global registry of acute
coronary events (GRACE) score and their combination in ACS risk stratification Ang, D.S., et al. Heart, 2009. 95(22): p. 1836-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19321492 84. Predicting freedom from clinical events in non-ST-elevation acute coronary
syndromes: the Global Registry of Acute Coronary Events Brieger, D., et al. Heart, 2009. 95(11): p. 888-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19246481 85. Sex-related differences in the presentation, treatment and outcomes among
patients with acute coronary syndromes: the Global Registry of Acute Coronary Events
Dey, S., et al. Heart, 2009. 95(1): p. 20-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=18463200 86. Evaluation of risk scores for risk stratification of acute coronary syndromes in the
Myocardial Infarction National Audit Project (MINAP) database Gale, C.P., et al. Heart, 2009. 95(3): p. 221-7.
87. Impact of acute and chronic risk factors on use of evidence-based treatments in
patients in Australia with acute coronary syndromes Joynt, K.E., et al. Heart, 2009. 95(17): p. 1442-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19460772 88. Simple point-of-care risk stratification in acute coronary syndromes: the AMIS
model Kurz, D.J., et al. Heart, 2009. 95(8): p. 662-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19066189 89. Secondhand smoke exposure and survival following acute coronary syndrome:
prospective cohort study of 1261 consecutive admissions among never-smokers Pell, J.P., et al. Heart, 2009. 95(17): p. 1415-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19684191 90. Prognostic value of coronary revascularisation-related myocardial injury: a
cardiac magnetic resonance imaging study Rahimi, K., et al. Heart, 2009. 95(23): p. 1937-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19687014 91. Choice of secondary prevention improves risk factors after acute coronary
syndrome: 1-year follow-up of the CHOICE (Choice of Health Options In prevention of Cardiovascular Events) randomised controlled trial
Redfern, J., et al. Heart, 2009. 95(6): p. 468-75. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=18801781 92. Immediate versus deferred coronary angioplasty in non-ST-segment elevation
acute coronary syndromes Riezebos, R.K., et al. Heart, 2009. 95(10): p. 807-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19098058 93. Pregnancy in high risk cardiac conditions Roos-Hesselink, J.W., J.J. Duvekot, and S.A. Thorne Heart, 2009. 95(8): p. 680-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19329725 94. Delay to angiography and outcomes following presentation with high-risk,
non-ST-elevation acute coronary syndromes: results from the Global Registry of Acute Coronary Events
Swanson, N., et al. Heart, 2009. 95(3): p. 211-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=18801782 95. Chest pain in the emergency department: role of cardiac imaging Wackers, F.J. Heart, 2009. 95(12): p. 1023-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19478114 96. Role of clopidogrel loading dose in patients with ST-segment elevation
myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial
Dangas, G., et al. J Am Coll Cardiol, 2009. 54(15): p. 1438-46. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19796737 97. Prognostic value of biomarkers during and after non-ST-segment elevation acute
coronary syndrome Eggers, K.M., et al. J Am Coll Cardiol, 2009. 54(4): p. 357-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19608034
98. Relationship of oxidized phospholipids and biomarkers of oxidized low-density
lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial
Fraley, A.E., et al. J Am Coll Cardiol, 2009. 53(23): p. 2186-96. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19497447 99. Effect of intensive statin therapy on regression of coronary atherosclerosis in
patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study)
Hiro, T., et al. J Am Coll Cardiol, 2009. 54(4): p. 293-302. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19608026 100. Coronary computed tomography angiography for early triage of patients with
acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial
Hoffmann, U., et al. J Am Coll Cardiol, 2009. 53(18): p. 1642-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19406338 101. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute
coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial
Jolly, S.S., et al. J Am Coll Cardiol, 2009. 54(5): p. 468-76. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19628124 102. Advanced age, antithrombotic strategy, and bleeding in non-ST-segment
elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
Lopes, R.D., et al. J Am Coll Cardiol, 2009. 53(12): p. 1021-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19298914 103. Computed tomographic angiography characteristics of atherosclerotic plaques
subsequently resulting in acute coronary syndrome Motoyama, S., et al. J Am Coll Cardiol, 2009. 54(1): p. 49-57. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19555840 104. Gastrointestinal bleeding in patients with acute coronary syndromes: incidence,
predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
Nikolsky, E., et al. J Am Coll Cardiol, 2009. 54(14): p. 1293-302. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19778672 105. The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa
inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis
O'Donoghue, M., et al. J Am Coll Cardiol, 2009. 54(8): p. 678-85. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19679245 106. Prognostic significance of periprocedural versus spontaneously occurring
myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
Prasad, A., et al. J Am Coll Cardiol, 2009. 54(5): p. 477-86. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19628125 107. Ischemia detected on continuous electrocardiography after acute coronary
syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With
Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial
Scirica, B.M., et al. J Am Coll Cardiol, 2009. 53(16): p. 1411-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19371824 108. Normal plasma levels of cardiac troponin I measured by the high-sensitivity
cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia
Venge, P., et al. J Am Coll Cardiol, 2009. 54(13): p. 1165-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19761938 109. Early statin therapy in acute coronary syndromes: the successful cycle of
evidence, guidelines, and implementation Waters, D.D. and I. Ku J Am Coll Cardiol, 2009. 54(15): p. 1434-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19796736 110. Sex differences in mortality following acute coronary syndromes Berger, J.S., et al. JAMA, 2009. 302(8): p. 874-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19706861 111. Risk of adverse outcomes associated with concomitant use of clopidogrel and
proton pump inhibitors following acute coronary syndrome Ho, P.M., et al. JAMA, 2009. 301(9): p. 937-44. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19258584 112. Immediate vs delayed intervention for acute coronary syndromes: a randomized
clinical trial Montalescot, G., et al. JAMA, 2009. 302(9): p. 947-54. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19724041
113. Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS
ACS-TIMI 46): a randomised, double-blind, phase II trial Mega, J.L., et al. Lancet, 2009. 374(9683): p. 29-38. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19539361 114. Otamixaban for the treatment of patients with non-ST-elevation acute coronary
Sabatine, M.S., et al. Lancet, 2009. 374(9692): p. 787-95. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19717184 115. Early versus delayed, provisional eptifibatide in acute coronary syndromes Giugliano, R.P., et al. N Engl J Med, 2009. 360(21): p. 2176-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19332455 116. Early versus delayed invasive intervention in acute coronary syndromes Mehta, S.R., et al. N Engl J Med, 2009. 360(21): p. 2165-75. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19458363 117. Ticagrelor versus clopidogrel in patients with acute coronary syndromes Wallentin, L., et al. N Engl J Med, 2009. 361(11): p. 1045-57. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19717846 118. Age-related differences in virtual histology-intravascular ultrasound findings in
patients with coronary artery disease Hong, Y.J., et al. J Cardiol, 2010. 55(2): p. 224-231. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20206076
119. Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker
affecting basal heart rate in myocardial infarction Vuilleumier, N., et al. Eur Heart J, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20176799 120. Aspects on the intensity and the relief of pain in the prehospital phase of acute
coronary syndrome: experiences from a randomized clinical trial Zedigh, C., et al. Coron Artery Dis, 2010. 21(2): p. 113-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20124885 121. Aspirin administration in ED patients who presented with undifferentiated chest
pain: age, race, and sex effects Takakuwa, K.M., F.S. Shofer, and J.E. Hollander Am J Emerg Med, 2010. 28(3): p. 318-24. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20223389 122. Assessment of ischemia-modified albumin levels for emergency room diagnosis
of acute coronary syndrome Shen, X.L., et al. Int J Cardiol, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20202711 123. Characteristics and outcome of patients with acute coronary syndrome and
normal or near-normal coronary angiography Minha, S., et al. Coron Artery Dis, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20308879 124. Clinical outcome after acute coronary syndrome in Japanese patients: An
observational cohort study Nakamura, M., et al. J Cardiol, 2010. 55(1): p. 69-76.
125. A comparison of clinical presentations, angiographic patterns and outcomes of
in-stent restenosis between bare metal stents and drug eluting stents Rathore, S., et al. EuroIntervention, 2010. 5(7): p. 841-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20142201 126. Coronary Artery Calcium Scoring in the Emergency Department: Identifying
Which Patients With Chest Pain Can Be Safely Discharged Home Nabi, F., et al. Ann Emerg Med, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20138399 127. Coronary heart disease in postmenopausal recipients of estrogen plus progestin
therapy: does the increased risk ever disappear? A randomized trial Toh, S., et al. Ann Intern Med, 2010. 152(4): p. 211-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20157135 128. Coronary Revascularization Strategy for ST Elevation Myocardial Infarction with
Multivessel Disease: Experience and Results at 1-Year Follow-Up Mohamad, T., et al. Am J Ther, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20027110 129. Coronary score adds prognostic information for patients with acute coronary
syndrome Huang, G., et al. Circ J, 2010. 74(3): p. 490-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20057158 130. Correlation of thrombolysis in myocardial infarction (TIMI) risk score with extent
of coronary artery disease in patients with acute coronary syndrome
Lakhani, M.S., et al. J Pak Med Assoc, 2010. 60(3): p. 197-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20225777 131. Cost-effectiveness of prasugrel versus clopidogrel in patients with acute coronary
syndromes and planned percutaneous coronary intervention: results from the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with Prasugrel-Thrombolysis in Myocardial Infarction TRITON-TIMI 38
Mahoney, E.M., et al. Circulation, 2010. 121(1): p. 71-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20026770 132. CYP1A1 MSPI (T6235C) gene polymorphism is associated with mortality in
acute coronary syndrome patients Jarvis, M.D., et al. Clin Exp Pharmacol Physiol, 2010. 37(2): p. 193-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19650794 133. Differences in mortality in acute coronary syndrome symptom clusters Riegel, B., et al. Am Heart J, 2010. 159(3): p. 392-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20211300 134. Differential levels of circulating progenitor cells in acute coronary syndrome
patients with a first event versus patients with recurring events Porto, I., et al. Int J Cardiol, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20053471 135. Effects of labetalol on hemodynamic parameters and soluble biomarkers of
inflammation in acute coronary syndrome in patients with active cocaine use Hoskins, M.H., et al. J Cardiovasc Pharmacol Ther, 2010. 15(1): p. 47-52. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20133495
136. Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in
routine clinical care (SORT OUT III): a randomised controlled superiority trial Rasmussen, K., et al. Lancet, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
prognosis in low-risk patients Vikenes, K., et al. Scand Cardiovasc J, 2010. 44(2): p. 69-75. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19670037 138. Eosinophil cationic protein: A new biomarker of coronary atherosclerosis Niccoli, G., et al. Atherosclerosis, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20307883 139. Factors related to heart rupture in acute coronary syndromes in the Global
Registry of Acute Coronary Events Lopez-Sendon, J., et al. Eur Heart J, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20231153 140. Gender differences in the treatment of non-ST-segment elevation myocardial
infarction Tavris, D., et al. Clin Cardiol, 2010. 33(2): p. 99-103. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20186991 141. Gender perspective on risk factors, coronary lesions and long-term outcome in
young patients with ST-elevation myocardial infarction Lawesson, S.S., et al. Heart, 2010. 96(6): p. 453-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20299414
142. [Peculiarities of Dynamics and Prognostic Value of NT-proBNP Level in Different
Variants of Treatment of Patients With Acute Coronary Syndrome.] Shreider, E.V., et al. Kardiologiia, 2010. 50(2): p. 15-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20146673 143. Plasma cystatin C for prediction of 1-year cardiac events in Mediterranean
patients with non-ST elevation acute coronary syndrome Taglieri, N., et al. Atherosclerosis, 2010. 209(1): p. 300-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19819453 144. Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary
syndrome Zhang, X., et al. Cell Stress Chaperones, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20300983 145. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to
percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement
Lazzeri, C., et al. J Cardiovasc Med (Hagerstown), 2010. 11(1): p. 7-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19829142 146. Pre-hospital ECG for acute coronary syndrome in urban India: A
cost-effectiveness analysis Schulman-Marcus, J., D. Prabhakaran, and T.A. Gaziano BMC Cardiovasc Disord, 2010. 10(1): p. 13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20222987 147. Prognostic modeling of individual patient risk and mortality impact of ischemic
and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial
Pocock, S.J., et al. Circulation, 2010. 121(1): p. 43-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20026777 148. Prognostic value of myeloperoxidase in coronary artery disease: comparison of
unstable and stable angina patients Roman, R.M., et al. Coron Artery Dis, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20305551 149. Psoriasis may not be an independent risk factor for acute ischemic heart disease
hospitalizations: results of a large population-based Dutch cohort Wakkee, M., R.M. Herings, and T. Nijsten J Invest Dermatol, 2010. 130(4): p. 962-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19812600 150. Relationship between serum vasoactive factors and plaque morphology in
patients with non-ST-segment elevated acute coronary syndrome Lu, Y.F., S.Z. Lu, and Y.D. Chen Chin Med J (Engl), 2010. 123(2): p. 193-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20137369 151. Subclinical myocardial necrosis and cardiovascular risk in stable patients
undergoing elective cardiac evaluation Tang, W.H., et al. Arterioscler Thromb Vasc Biol, 2010. 30(3): p. 634-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=20032289 152. Towards risk stratification in systemic atherosclerosis: value of myocardial
function and viability imaging as an adjunct to MR angiography Seeger, A., et al. Eur Radiol, 2010. 20(4): p. 838-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
n&list_uids=19760234
153. Treatment with 5-Lipoxygenase Inhibitor VIA-2291 (Atreleuton) in Patients with Recent Acute Coronary Syndrome
Tardif, J.C., et al. Circ Cardiovasc Imaging, 2010. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citatio
